Human neutrophils have a short half-life and are believed to die by apoptos
is or programmed cell death both in vivo and in vitro. We found that caspas
es are activated in a time-dependent manner in neutrophils undergoing spont
aneous apoptosis, concomitant with other characteristic features of apoptot
ic cell death such as morphologic changes, phosphatidylserine (PS) exposure
, and DNA fragmentation. The treatment of neutrophils with agonistic anti-f
as monoclonal antibodies (MoAbs) significantly accelerated this process, Ho
wever, in cells treated with the potent neutrophil activator phorbol 12-myr
istate 13-acetate (PMA), caspase activity was only evident after pharmacolo
gic inhibition of the nicotinamide adenine dinucleotide phosphate (NADPH) o
xidase. Similarily, inhibition of the NADPH oxidase in constitutive and Fas
/APO-1-triggered apoptosis resulted in increased rather than suppressed lev
els of caspase activity, suggesting that reactive oxygen species may preven
t caspases from functioning optimally in these cells. Moreover, oxidants ge
nerated via the NADPH oxidase were essential for PS exposure during PMA-ind
uced cell death, but not for neutrophils undergoing spontaneous apoptosis.
We conclude that caspases are an important component of constitutive and Fa
s/APO-1-triggered neutrophil apoptosis. However, these redox sensitive enzy
mes are suppressed in activated neutrophils, and an alternate oxidant-depen
dent pathway is used to mediate PS exposure and neutrophil clearance under
these conditions. (C) 1998 by The American Society of Hematology.